The use of incretin-based therapies and cancer-specific risk in type 2 diabetes mellitus patients: a systematic review

Original language	English
Publication status	Published - 18 Apr 2021
Event	International Society of Pharmacoepidemiology Mid-Year Meeting 2021 - Orlando, United States Duration: 18 Apr 2021 → 21 Apr 2021

Conference

Conference	International Society of Pharmacoepidemiology Mid-Year Meeting 2021
Country/Territory	United States
City	Orlando
Period	18/04/2021 → 21/04/2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 

Student theses

• An investigation of the effect of hormonal medications, sex hormones, and inflammatory factors on cancer risk

  Doherty, N. (Author), Cardwell, C. (Supervisor) & Hicks, B. (Supervisor), Jul 2024

  Student thesis: Doctoral Thesis › Doctor of Philosophy

  File

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

McGuckin, N., Cardwell, C., & Hicks, B. (2021). The use of incretin-based therapies and cancer-specific risk in type 2 diabetes mellitus patients: a systematic review. Poster session presented at International Society of Pharmacoepidemiology Mid-Year Meeting 2021, Orlando, Florida, United States.

McGuckin, Niamh ; Cardwell, Christopher ; Hicks, Blánaid. / The use of incretin-based therapies and cancer-specific risk in type 2 diabetes mellitus patients: a systematic review. Poster session presented at International Society of Pharmacoepidemiology Mid-Year Meeting 2021, Orlando, Florida, United States.

@conference{49452f5852024e668aed329fe3de398f,

title = "The use of incretin-based therapies and cancer-specific risk in type 2 diabetes mellitus patients: a systematic review",

author = "Niamh McGuckin and Christopher Cardwell and Bl{\'a}naid Hicks",

year = "2021",

month = apr,

day = "18",

language = "English",

note = "International Society of Pharmacoepidemiology Mid-Year Meeting 2021 ; Conference date: 18-04-2021 Through 21-04-2021",

}

McGuckin, N, Cardwell, C & Hicks, B 2021, 'The use of incretin-based therapies and cancer-specific risk in type 2 diabetes mellitus patients: a systematic review', International Society of Pharmacoepidemiology Mid-Year Meeting 2021, Orlando, United States, 18/04/2021 - 21/04/2021.

The use of incretin-based therapies and cancer-specific risk in type 2 diabetes mellitus patients: a systematic review. / McGuckin, Niamh; Cardwell, Christopher; Hicks, Blánaid.
2021. Poster session presented at International Society of Pharmacoepidemiology Mid-Year Meeting 2021, Orlando, Florida, United States.

Research output: Contribution to conference › Poster

TY - CONF

T1 - The use of incretin-based therapies and cancer-specific risk in type 2 diabetes mellitus patients: a systematic review

AU - McGuckin, Niamh

AU - Cardwell, Christopher

AU - Hicks, Blánaid

PY - 2021/4/18

Y1 - 2021/4/18

M3 - Poster

T2 - International Society of Pharmacoepidemiology Mid-Year Meeting 2021

Y2 - 18 April 2021 through 21 April 2021

ER -

McGuckin N, Cardwell C, Hicks B. The use of incretin-based therapies and cancer-specific risk in type 2 diabetes mellitus patients: a systematic review. 2021. Poster session presented at International Society of Pharmacoepidemiology Mid-Year Meeting 2021, Orlando, Florida, United States.